Industry Spotlight
Applications now open for expanded prestigious science awards
18 May 2012: Minister for Innovation, Services and Small Business Louise Asher today announced applications are now open for the 2012 Victoria Prize for Science and Innovation, and the 2012 Victoria Fellowships. Ms Asher said the Victorian Coalition Government was... | READ MORE
Australian-discovered biomarkers map path to new blood test for bowel cancer
20 May 2012: A team of Australian scientists has identified new genes that show identifiable changes in the blood of people with bowel cancer. The discovery has the potential to underpin a new cost-effective blood test that would signal the early stages of bowel can... | READ MORE
Geoff McDonald appointed General Manager GlaxoSmithKline Australia
15 May 2012: Geoff McDonald has been appointed General Manager of GlaxoSmithKline (GSK) Australia following the departure of Deborah Waterhouse. GSK Asia Pacific Senior Vice President & Area Director, Fabio Landazabal, said “Geoffs multi-market experience and ... | READ MORE
Leading fund manager snares star biotech and healthcare analyst
15 May 2012: New-look Octa Phillip Bioscience Managers (OP Bioscience Managers) is looking to create an all‐star team with the addition of Starmine top rated analyst Dr Graeme Wald as it progresses towards a first close on its second fund. With its first fund... | READ MORE
2012 Science Excellence Awards for South Australia
10 May 2012: The Science Excellence Awards are South Australias premier science event, showcasing the success of the States scientists, researchers, PhD students and STEM educators. Do you know any promising PhD recent graduates who are making a mark in the science... | READ MORE
New National Manager for TGA
2 May 2012: The Federal Government's Department of Health and Ageing has appointed Dr John Skerritt as the new National Manager of the Therapeutic Goods Administration (TGA). The Secretary of the Department, Professor Jane Halton, said Dr John Skerritt, who has a P... | READ MORE
pSivida receives first marketing authorisation for Iluvien in Europe
26 April 2012: pSivida (ASX:PVA, NASDAQ:PSDV) has received its first approval in Europe for the sale of Iluvien, a treatment for Chronic Diabetic Macular Edema (Chronic DME). Austria has granted marketing authorisation of Iluvien. The other Concerned Member States (... | READ MORE
Australian vaccine delivery investment wins global award
23 April 2012: UniQuest congratulates Nanopatch vaccine technology developer Vaxxas Pty Ltd and its investors on winning the prestigious 2012 Best Venture Capital Investment prize in the Vaccine Industry Excellence (ViE) Awards at the World Vaccine Congress in Washi... | READ MORE
2012 Victoria Prize and Fellowships
20 April 2012: The $50,000 Victoria Prize is awarded annually to an individual whose scientific discovery or technological innovation has significantly advanced knowledge or has potential to lead to a commercial outcome or other benefit to the community. Created in... | READ MORE
New institute to lead climate change research
10 April 2012: Last weeks opening of the Hawkesbury Institute for the Environment at the University of Western Sydney provides Australia with a world-class research institute to tackle the impacts of climate change. In opening the facility, Senator Chris Evans, the... | READ MORE